416 related articles for article (PubMed ID: 26937558)
1. Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.
Ma R; Chaudhari S; Li W
Antioxid Redox Signal; 2016 Nov; 25(13):732-748. PubMed ID: 26937558
[TBL] [Abstract][Full Text] [Related]
2. TRPC Channels in Proteinuric Kidney Diseases.
Hall G; Wang L; Spurney RF
Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
[TBL] [Abstract][Full Text] [Related]
3. Transient receptor potential channel 6 knockdown prevents apoptosis of renal tubular epithelial cells upon oxidative stress via autophagy activation.
Hou X; Xiao H; Zhang Y; Zeng X; Huang M; Chen X; Birnbaumer L; Liao Y
Cell Death Dis; 2018 Oct; 9(10):1015. PubMed ID: 30282964
[TBL] [Abstract][Full Text] [Related]
4. Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes.
Kim EY; Alvarez-Baron CP; Dryer SE
Mol Pharmacol; 2009 Mar; 75(3):466-77. PubMed ID: 19052171
[TBL] [Abstract][Full Text] [Related]
5. High glucose modifies transient receptor potential canonical type 6 channels via increased oxidative stress and syndecan-4 in human podocytes.
Thilo F; Lee M; Xia S; Zakrzewicz A; Tepel M
Biochem Biophys Res Commun; 2014 Jul; 450(1):312-7. PubMed ID: 24942878
[TBL] [Abstract][Full Text] [Related]
6. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
[No Abstract] [Full Text] [Related]
7. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
[TBL] [Abstract][Full Text] [Related]
8. High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species.
Liu BC; Song X; Lu XY; Li DT; Eaton DC; Shen BZ; Li XQ; Ma HP
Biochim Biophys Acta; 2013 Jun; 1833(6):1434-42. PubMed ID: 23499875
[TBL] [Abstract][Full Text] [Related]
9. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
10. The role of TRPC6 in oxidative stress-induced podocyte ischemic injury.
Zhao B; Yang H; Zhang R; Sun H; Liao C; Xu J; Meng K; Jiao J
Biochem Biophys Res Commun; 2015 May; 461(2):413-20. PubMed ID: 25896763
[TBL] [Abstract][Full Text] [Related]
11. Role of TRPC6 in Progression of Diabetic Kidney Disease.
Staruschenko A; Spires D; Palygin O
Curr Hypertens Rep; 2019 May; 21(7):48. PubMed ID: 31115705
[TBL] [Abstract][Full Text] [Related]
12. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes.
Graham S; Gorin Y; Abboud HE; Ding M; Lee DY; Shi H; Ding Y; Ma R
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C304-15. PubMed ID: 21525431
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A
Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854
[TBL] [Abstract][Full Text] [Related]
14. Balancing calcium signals through TRPC5 and TRPC6 in podocytes.
Greka A; Mundel P
J Am Soc Nephrol; 2011 Nov; 22(11):1969-80. PubMed ID: 21980113
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species-mediated TRPC6 protein activation in vascular myocytes, a mechanism for vasoconstrictor-regulated vascular tone.
Ding Y; Winters A; Ding M; Graham S; Akopova I; Muallem S; Wang Y; Hong JH; Gryczynski Z; Yang SH; Birnbaumer L; Ma R
J Biol Chem; 2011 Sep; 286(36):31799-809. PubMed ID: 21768109
[TBL] [Abstract][Full Text] [Related]
16. Capsazepine (CPZ) Inhibits TRPC6 Conductance and Is Protective in Adriamycin-Induced Nephropathy and Diabetic Glomerulopathy.
Hagmann H; Khayyat NH; Matin M; Oezel C; Chen H; Schauss A; Schell C; Benzing T; Dryer S; Brinkkoetter PT
Cells; 2023 Jan; 12(2):. PubMed ID: 36672207
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
Li Z; Xu J; Xu P; Liu S; Yang Z
Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
[TBL] [Abstract][Full Text] [Related]
18. Sustained activation of N-methyl-D-aspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death.
Kim EY; Anderson M; Dryer SE
Mol Pharmacol; 2012 Oct; 82(4):728-37. PubMed ID: 22828802
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II activation of TRPC6 channels in rat podocytes requires generation of reactive oxygen species.
Anderson M; Roshanravan H; Khine J; Dryer SE
J Cell Physiol; 2014 Apr; 229(4):434-42. PubMed ID: 24037962
[TBL] [Abstract][Full Text] [Related]
20. Transient Receptor Potential Canonical 6 (TRPC6) Channel in the Pathogenesis of Diseases: A Jack of Many Trades.
Saqib U; Munjuluri S; Sarkar S; Biswas S; Mukherjee O; Satsangi H; Baig MS; Obukhov AG; Hajela K
Inflammation; 2023 Aug; 46(4):1144-1160. PubMed ID: 37072606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
